Intravenous CellCept

By making the immune system less active, CellCept® (mycophenolate mofetil) can help prevent organ rejection after a kidney, liver, or heart transplant.
CellCept comes as an intravenous (IV) injection, a capsule, a tablet, and an oral liquid suspension. Your dose will depend on several factors, including your age, weight, and other medical conditions you may have. The capsules, tablets, and liquid are typically taken by mouth twice daily. The injectable form is administered as a slow injection (called an infusion) into a vein (intravenously, or by IV) twice a day.
The CellCept intravenous injection is only recommended for people who cannot swallow the tablets, capsules, or liquid. It should only be used as long as oral medicines are not tolerated, for up to 14 days.
(For more information on the intravenous form of this drug, click CellCept. This article explains how this medicine works, describes dosing guidelines, and lists other important safety precautions to be aware of.)
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.